Your browser doesn't support javascript.
loading
A 27-Year-Old Primigravida with a Right Renal Cell Carcinoma Removed at 30 Weeks of Gestation by Robot-Assisted Retroperitoneoscopic Partial Nephrectomy.
Völler, Moritz; Mahmud, Walid; Vallo, Stefan; Grabbert, Markus; John, Patricia; Khoder, Wael Y.
Afiliación
  • Völler M; Department of Urology, Darmstadt Hospital, Hessen, Germany.
  • Mahmud W; Department of Urology, Hochtaunus-Hospitals, Bad Homburg vor der Höhe, Germany.
  • Vallo S; Department of Urology, Hochtaunus-Hospitals, Bad Homburg vor der Höhe, Germany.
  • Grabbert M; Department of Urology, Freiburg University, Freiburg in Breisgau, Germany.
  • John P; Department of Urology, University Hospital, Köln, Germany.
  • Khoder WY; Department of Urology, Freiburg University, Freiburg in Breisgau, Germany.
Am J Case Rep ; 22: e927164, 2021 Apr 18.
Article en En | MEDLINE | ID: mdl-33866322
ABSTRACT
BACKGROUND Large renal tumors during pregnancy are rare findings (0.07-0.1%). Current guidelines recommend surgical removal. This surgery should be carefully planned in an interdisciplinary team and involves special risks for mother and fetus. This report describes a case of a 27-year-old primigravida woman with a right renal cell carcinoma involving the lower pole of the kidney, which was removed at 30 weeks of gestation by robot-assisted retroperitoneoscopic partial nephrectomy (RARPN). CASE REPORT The patient was referred by the treating obstetrician with a newly diagnosed right lower pole renal mass of 6×4 cm in greatest diameter extending deeply into the parenchyma. No metastasis or enlarged lymph nodes were described in subsequent magnetic resonance tomography. Clinical and laboratory examinations documented a healthy mother and fetus. A right-sided RARPN was advised and planned by an interdisciplinary team of treating physicians (gynecologists, oncologists, and urologists). The surgery was conducted under general anesthesia with an obstetrician on stand-by. Surgery was performed without any complications (operation time 95 min, renal-ischemia time 15 min, and negligible blood loss) and histopathology confirmed the diagnosis of a chromophobe renal cell carcinoma. Further follow-up consultations showed regular wound healing and normal progression of pregnancy, and the patient gave birth to a healthy child at term. Follow-up examinations of the patient were uneventful. CONCLUSIONS This case shows that RARPN can be a safe and effective surgical procedure for partial nephrectomy during pregnancy, where surgery is performed in a specialist center and by an interdisciplinary experienced surgical team. It seems to offer advantages and better risk profile over the laparoscopic approach.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones Neoplásicas del Embarazo / Carcinoma de Células Renales / Laparoscopía / Procedimientos Quirúrgicos Robotizados / Neoplasias Renales / Nefrectomía Tipo de estudio: Guideline Límite: Adult / Child / Female / Humans / Pregnancy Idioma: En Revista: Am J Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones Neoplásicas del Embarazo / Carcinoma de Células Renales / Laparoscopía / Procedimientos Quirúrgicos Robotizados / Neoplasias Renales / Nefrectomía Tipo de estudio: Guideline Límite: Adult / Child / Female / Humans / Pregnancy Idioma: En Revista: Am J Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Alemania